Tranexamic acid therapy for heavy menstrual bleeding

Bibliography

• National Collaborating Centre for Women’s and Children’s Health. Heavy Menstrual Bleeding. London: RCOG Press; 2007. Available from: http://guidance.nice.org.uk/CG44
   Google Scholar
• Smith SK, Smith SK. Hysterectomy—why and when? In: Smith SK. editor. Dysfunctional uterine bleeding. Royal Society of Medicine Press; London: 1994. p. 107
   Google Scholar
• Oehler MK, Rees MC. Menorrhagia: an update. Acta Obstet Gynecol Scand 2003;82:405-22
   PubMed Web of Science ®Google Scholar
• Shankar M, Lee CA, Sabin CA, von Willebrand disease in women with menorrhagia: a systematic review. BJOG 2004;111(7):734-40
   PubMed Web of Science ®Google Scholar
• Wedisinghe L, Lumsden MA. Heavy Menstrual Bleeding. In: Mahmood T, Templeton A, Dhillon C. editors. Models of Care in Women’s Health. RCOG Press; London: 2009. p. 67-80
   Google Scholar
• British National Formulary. ( Volume 61). BMJ Publishing Group Ltd and RPS Publishing, London; 2011
   Google Scholar
• Coulter A, Kelland J, Peto V, Rees MC. Menorrhagia in primary care: an overview of drug trials and a survey of prescribing practice. Int J Technol Assess Health Care 1995;11(3):456-71
   PubMed Web of Science ®Google Scholar
• Wellington K, Wagstaff AJ. Tranexamic acid: a review of its use in the management of menorrhagia. Drugs 2003;63(13):1417-33
   PubMed Web of Science ®Google Scholar
• Thorsen S. Differences in the binding to fibrin of native plasminogen and plasminogen modified by proteolytic degredation: influence of omega-aminocarboxylic acids. Biochim Biophys Acta 1975;393:55-65
   PubMedGoogle Scholar
• Gleeson NC, Buggy F, Sheppard BL, The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding. Acta Obstet Gynecol Scand 1994;73:274-7
   PubMed Web of Science ®Google Scholar
• Dockeray CJ, Sheppard BL, Daily L, Bonnar J. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid. Eur J Obstet Gynecol Reprod Biol 1987;24(4):309-18
   PubMed Web of Science ®Google Scholar
• Moodley J, Cohen M, Devraj K, Dutton M. Vaginal absorption of low-dose tranexamic acid from impregnated tampons. S Afr Med J 1992;81(3):150-2
   PubMed Web of Science ®Google Scholar
• Eriksson O, Kjellman H, Schannong M. The biological availability of Cyklokapron solution administered orally. Data on file, Kabi AB; Stockholm: 1971
   Google Scholar
• Verstraete M. Clinical application of inhibitors of fibrinolysis. Drugs 1985;29(3):236-61
   PubMed Web of Science ®Google Scholar
• Bonnar J, Sheppard BL. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid. BMJ 1996;313:579-82
   PubMed Web of Science ®Google Scholar
• Preston JT, Cameron IT, Adams EJ, Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 1995;102(5):401-6
   PubMedGoogle Scholar
• Milsom I, Andersson K, Andersch B, A comparison of flurbiprofen, tranexamic acid, and a levonorgestrel-releasing intrauterine contraceptive device in the treatment of idiopathic menorrhagia. Am J Obstet Gynecol 1991;164(3):879-83
   PubMed Web of Science ®Google Scholar
• Callender ST, Warner GT, Cope E. Treatment of menorrhagia with tranexamic acid: a double-blind trial. BMJ 1970;4(729):214-16
   PubMedGoogle Scholar
• Ylikorkala O, Viinikka L. Comparison between antifibrinolytic and antiprostaglandin treatment in the reduction of increased menstrual blood loss in women with intrauterine contraceptive devices. Br J Obstet Gynaecol 1983;90(1):78-83
   PubMedGoogle Scholar
• Srinil S, Jaisamrarn U. Treatment of idiopathic menorrhagia with tranexamic acid. J Med Assoc Thai 2005;88(2):S1-6
   PubMedGoogle Scholar
• Kouides PA, Byams VR, Philipp CS, Multisite management study of menorrhagia with abnormal laboratory haemostasis: a prospective crossover study of intranasal desmopressin and oral tranexamic acid. Br J Haematol 2009;145(2):212-20
   PubMed Web of Science ®Google Scholar
• Lukes AS, Moore KA, Muse KN, Tranexamic acid treatment for heavy menstrual bleeding: a randomized controlled trial. Obstet Gynecol 2010;116(4):865-75
   PubMed Web of Science ®Google Scholar
• Winkler UH. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2001;99(2):238-43
   PubMed Web of Science ®Google Scholar
• Lethaby A, Farquar C, Cooke I. Antifibrinolytics for heavy menstrual bleeding. Cochrane Database Syst Rev 2000(4):CD000249
   Google Scholar
• Demers C, Derzko C, Douglas J. Ggynecological and obstetric management of women with inherited bleeding disorders. Int J Gynecol Obstet 2006;95(1):75-87
   PubMed Web of Science ®Google Scholar
• Kadir RA, Lukes AS, Kouides PA, Management of excessive menstrual bleeding in women with hemostatic disorders. Fertil Steril 2005;84:1352-9
   PubMed Web of Science ®Google Scholar
• Kullander S, Nilsson IM. Human placental transfer Aof an antifibrinolytic agent (AMCA). Acta Obstet Gynecol Scand 1970;49(3):241-2
   PubMed Web of Science ®Google Scholar
• Nilsson IM. Haemorrhage and Thrombotic Diseases. John Wiley & Sins, Ltd; London: 1974
   Google Scholar
• Taparia M, Cordingley FT, Leahy MF. Pulmonary embolism associated with tranexamic acid in severe acqired haemophelia. Eur J Hematol 2002;68:307-9
   PubMed Web of Science ®Google Scholar
• Woo KS, Tse LK, Woo JL, Vallance-Owen J. Massive pulmonary thromboembolism after tranexamic acid antifibrinolytic therapy. Br J Clin Pract 1989;43:465-6
   PubMedGoogle Scholar
• Dunn CJ, Goa KL. TA: a review of its use in surgery and other indications. Drugs 1999;57(6):1005-32
   PubMed Web of Science ®Google Scholar
• Hippala ST, Strid LJ, Wennerstrand MI, Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997;84:839-44
   PubMed Web of Science ®Google Scholar
• Zhang B, Wieslander JB. Influence of early fibrinolysis inhibition on thrombus formation following microvascular trauma. Microsurgery 1996;17:278-85
   PubMed Web of Science ®Google Scholar
• Lindoff C, Rybo G, Astedt B. Treatment with tranexamic acid during pregnancy, and risk of thrombo-embolic complications. Thromb Haemost 1993;70:238-40
   PubMed Web of Science ®Google Scholar
• Sundstrom A, Seaman H, Kieler H, Alfredsson L. The risk of venous thromboembolism associated with the use of tranexamic acid and other drugs used to treat menorrhagia: a case-control study using the General Practice Research Database. Br J Obstet Gynaecol 2009;116:91-7
   Google Scholar
• Rybo G. Tranexamic acid therapy: effective treatment in heavy menstrual bleeding: clinical update on safety. Ther Adv 1991;4:1-8
   Google Scholar
• Winkler UH. The effect of tranexamic acid on the quality of life of women with heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol 2001;99(2):238-43
   PubMed Web of Science ®Google Scholar